XBiotech Shares Outstanding 2013-2021 | XBIT

XBiotech shares outstanding from 2013 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
XBiotech Annual Shares Outstanding
(Millions of Shares)
2020 31
2019 46
2018 36
2017 35
2016 32
2015 31
2014 24
2013 22
2012 21
XBiotech Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 30
2021-03-31 29
2020-12-31 31
2020-09-30 29
2020-06-30 29
2020-03-31 36
2019-12-31 46
2019-09-30 41
2019-06-30 38
2019-03-31 36
2018-12-31 36
2018-09-30 36
2018-06-30 36
2018-03-31 35
2017-12-31 35
2017-09-30 35
2017-06-30 35
2017-03-31 33
2016-12-31 32
2016-09-30 32
2016-06-30 32
2016-03-31 32
2015-12-31 31
2015-09-30 32
2015-06-30 31
2015-03-31 28
2014-12-31 24
2014-09-30 24
2014-06-30 24
2014-03-31 24
2013-12-31
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.452B $0.000B
XBiotech Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing True Human(TM) monoclonal antibodies for treating diseases. XBiotech Inc. is based in AUSTIN, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29